WHO ICTRP trial
A randomized, cross-over, dose-response trial of tyrosine and its effect on…
NL-OMON41127 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41127 |
|---|---|
| Public title | A randomized, cross-over, dose-response trial of tyrosine and its effect on working memory in healthy elderly and young people |
| Scientific title | A randomized, cross-over, dose-response trial of tyrosine and its effect on working memory in healthy elderly and young people - FOCOM DoReTy study |
| Primary sponsor | Wageningen Universiteit |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | cognitive performance mental health;10013511;cognitive performance;mental health |
| Interventions | Elderly participants receive three doses (100, 150 and 200 mg/kg bodyweight) of tyrosine and younger participants receive one dose (150 mg/kg body weight) of tyrosine. Tyrosine will be mixed with yoghurt. ;dose-response;elderly;Tyrosine |
| Registration date | Oct 6, 2014 |
| Target size | 34 |
| Secondary IDs | NL49893.081.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: